Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Green USA is the North American subsidiary of Qingdao Haotian Pharm Co., Ltd., a global leader in the production of natural ingredients and botanical extracts. The company specializes in high-intensity natural sweeteners, most notably Stevia under the SoPure brand, and Monk Fruit extracts. Additionally, they provide specialty nutraceutical ingredients such as Pyrroloquinoline Quinone (PurePQQ) and Inositol to the food, beverage, and dietary supplement industries. Headquartered in California, New Green USA manages sales, distribution, and technical support for the North American market, focusing on non-GMO and organic-certified products. The company bridges large-scale manufacturing capabilities with the rigorous quality and regulatory standards required by Western health and wellness brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Green USA.